Ligand validation:6S8S

CXS: 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID

CXS is a Ligand Of Interest in 6S8S designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6S8S_CXS_A_506	92%	53%	0.093	0.984	0.55	1.26	-	2	0	0	100%	1
6S8S_CXS_C_505	27%	65%	0.19	0.837	0.29	1.05	-	2	0	0	100%	1
6S8S_CXS_C_504	19%	64%	0.208	0.803	0.58	0.78	-	-	0	0	100%	1
6S8S_CXS_A_507	18%	52%	0.209	0.791	0.58	1.27	-	2	1	0	100%	1
6S8S_CXS_A_508	1%	69%	0.346	0.563	0.28	0.9	-	1	0	0	100%	1
2WAX_CXS_D_1227	84%	16%	0.119	0.98	1.84	1.84	1	5	0	0	100%	1
9AUQ_CXS_B_202	100%	16%	0.03	0.993	2.34	1.36	2	2	0	0	100%	1
6GAL_CXS_M_604	100%	35%	0.043	0.993	1.04	1.52	1	2	0	0	100%	1
2QGQ_CXS_F_501	99%	54%	0.054	0.987	0.76	1.03	-	1	0	0	100%	1
3OBL_CXS_B_134	98%	19%	0.058	0.981	2.3	1.18	2	3	0	0	100%	1
1RZL_CXS_A_201	97%	29%	0.067	0.984	1.4	1.44	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.